Information About NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring)
Stay in the Loop With NuvaRing

Complete the form below to start getting helpful updates, tips, and tools from NuvaRing. Answering the additional questions helps us choose the right information to share with you.

Merck’s Privacy Commitment

Get Updates for NuvaRing® (etonogestrel/ethinyl estradiol vaginal ring) The information you provide will be available to the Merck & Co., Inc., family of companies (collectively, “Merck”) and others working on behalf of Merck, and according to the same standards, to provide the information and services you request. Personal information about you will not otherwise be disclosed for marketing purposes without your permission. Merck reviews personal information and nonidentifiable information not only to provide the requested information and services but also to develop and offer additional services and communications that we believe our customers might find of interest. Merck also may use personal information to audit its resources for compliance and security purposes. For more information about how Merck protects personal information about you, please read the Internet Privacy Policy and Privacy Statement for U.S. Patients, Consumers, and Caregivers.


Registration
*Required fields, answers must be provided
*Required fields, answers must be provided
Error: please fill the required fields.
Error: please fill the required fields.
You must be 18 years or older to participate in the Stay in the Loop program.
You must be 18 years or older to participate in the Stay in the Loop program.
*First Name
*Last Name
*E-mail Address
*Address 1
Address 2
*City
*State
Select
 
*Zip Code
*Are you 18 years of age or older?
*Which of these statements best describes you?
*When is your next doctor visit at which you may discuss birth control options?    
Answering these questions helps us choose the right information to share with you.
*When did you start on NuvaRing? Select  
Answering these questions helps us choose the right information to share with you.
*When did you start on NuvaRing? Select  
Answering these questions helps us choose the right information to share with you.
 

By providing your name, address, and other personal information above and clicking the “submit” button below you agree to permit Merck and others working on behalf of Merck to use this information to provide you with resources, information and materials associated with NuvaRing and information resources, services and communications about NuvaRing via e-mail or otherwise. Additionally, your information may be used for market research purposes.

At any time, you can request a copy of this permission and that personal information about you be removed from the Merck contact list for NuvaRing by calling 1-888-776-8364. Unless you change this selection sooner, your permission will expire 1 year after Merck no longer promotes NuvaRing.

By clicking “submit” I understand that I am signing this form and that the information I have provided may be used as described above.

 
Important Safety Information
Do not use NuvaRing if you smoke cigarettes and are over age 35. Smoking increases your risk of serious heart and blood vessel problems from combination hormonal contraceptives (CHCs) including heart attack, blood clots, or stroke which can be fatal. This risk increases with age and the number of cigarettes smoked.
  • The use of a CHC, like NuvaRing, is associated with increased risks of several serious side effects, including blood clots, stroke, or heart attack. NuvaRing is not for women with a history of these conditions or any condition that makes your blood more likely to clot. The risk of getting blood clots may be greater with the type of progestin in NuvaRing than with some other progestins in certain low-dose birth control pills. The risk of blood clots is highest when you first start using CHCs and when you restart the same or different CHC after not using it for a month or more.  
  • NuvaRing is also not for women with high blood pressure that medicine can’t control; diabetes with kidney, eye, nerve, or blood vessel damage; certain kinds of severe migraine headaches; liver disease or liver tumors; unexplained vaginal bleeding; breast cancer or any cancer that is sensitive to female hormones; or if you are or may be pregnant.
  • NuvaRing does not protect against HIV infection (AIDS) and other sexually transmitted infections.
  • The most common side effects reported by users of NuvaRing are irritation inside your vagina or on your cervix; headache (including migraine); mood changes (including depression); the ring slipping out or causing discomfort; nausea and vomiting; vaginal discharge; weight gain; vaginal discomfort; breast pain, discomfort, or tenderness; painful menstrual periods; abdominal pain; acne; and less sexual desire.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please read the Patient Information for NuvaRing (etonogestrel/ethinyl estradiol vaginal ring), including the information about the increased risk of serious cardiovascular side effects, especially in women who smoke, and discuss it with your health care provider. The physician Prescribing Information also is available.


Learn more about NuvaRing: Call 1-877-NUVARING (1-877-688-2746)
Learn more about NuvaRing: Call 1-877-NUVARING (1-877-688-2746)